ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BOLD vs RNXT // NET PROFIT MARGIN

Boundless Bio Inc. (NASDAQ) VS. RenovoRx Inc. (NASDAQ) • 15-METRIC TALLY: BOLD 1 — RNXT 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BOLD VS. RNXT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BOLD RNXT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 70.90% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -16.32% — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin ACTIVE — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 180.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.40 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 4/9 -1.00 RNXT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.9 43.0 +0.90 BOLD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $56.4M $56.9M -$477.4K RNXT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BOLD REV RNXT REV BOLD GROSS % RNXT GROSS % BOLD FCF RNXT FCF
FY 2025 $177.9M $1.1M — 70.9% -$47.2M -$11.0M
FY 2024 $205.1M $43.0K — 98.0% -$63.4M -$9.1M
FY 2023 $153.4M $31.9M — — -$46.9M -$10.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BOLD // BETA —
RNXT // BETA —